| Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020) |
|---|
| 04/23/2008 | EP1912657A2 Metered-dose and safety and compliance packaging for systemic anticancer therapy |
| 04/23/2008 | EP1723160A4 Toll-like receptor 2 (tlr-2) haplotypes predict outcome of patients |
| 04/23/2008 | EP1578431A4 Fat regulation |
| 04/23/2008 | EP1476141B1 Tamper-resistant transdermal opioid delivery devices |
| 04/23/2008 | EP1474145B1 Quinoline derivatives as npy antagonists |
| 04/23/2008 | EP1462457B1 Cytotoxic protein and utilization thereof |
| 04/23/2008 | EP1372712B1 Equine herpesvirus vaccine |
| 04/23/2008 | EP1372673B1 The use of non-digestible polymeric foams to sequester ingested materials, thereby inhibiting their absorption by the body |
| 04/23/2008 | EP1220921B1 Nucleic acid sequences of hyperplasia and tumours of the thyroid |
| 04/23/2008 | EP1061962B1 Disposable absorbent article having a skin care composition containing an enzyme inhibitor |
| 04/23/2008 | EP1007033B1 Lymphocyte function antigen-1 antagonists |
| 04/23/2008 | CN101166543A Composition containing antidementia agent |
| 04/23/2008 | CN101166534A Therapeutic agent for chronic obstructive pulmonary disease |
| 04/23/2008 | CN101166519A Dosage forms of risedronate |
| 04/23/2008 | CN101164621A Super-paramagnetic composite particle drug-loaded body and preparation method thereof |
| 04/23/2008 | CN101164618A A combination of fbpase inhibitors and insulin sensitizers for the treatment of diabetes |
| 04/23/2008 | CN101164617A Combination drug therapy for reducing scar tissue formation |
| 04/23/2008 | CN101164616A Uses of anti-insulin-like growth factor 1 receptor antibodies |
| 04/23/2008 | CN101164548A Pharmaceutical compositions comprising an adenosine receptor agonist or antagonist |
| 04/23/2008 | CN101164541A Treatment of urinary dysfunction |
| 04/23/2008 | CN100383124C Quinoline derivatives as NPY antagonists |
| 04/23/2008 | CN100382844C Soluble lymphotoxin-beta receptors, anti-lymphotoxin receptor antibodies, and use of anti-lymphotoxin ligand antibodies |
| 04/23/2008 | CN100382804C Use of n-substituted-1,5-dideoxy-1,5-imino-d-glucitol compounds in combination therapy for treating hepatitis virus infections |
| 04/23/2008 | CN100382803C Topical composition containing at least one vitamin D or one vitamin D analogue and at least one corticosteroid |
| 04/22/2008 | US7361787 Prophylaxis of respiratory disorders and therapy, also metod of synthesis and composition with PDE4 inhibitor, corticosteroid hibitor or anticholinergic agent |
| 04/22/2008 | US7361748 Protease for identifying modulators for treatment and prevention of thrombocytopenia and liver disorders |
| 04/22/2008 | US7361691 Method of treating cancers using β-lapachone or analogs or derivatives thereof |
| 04/22/2008 | US7361681 Method of treating amytrophic lateral sclerosis using melatonin |
| 04/22/2008 | US7361678 Azole derivatives and fused bicyclic azole derivatives as therapeutic agents |
| 04/22/2008 | US7361677 Polycyclic sulphamate compounds suitable for use as inhibitors of aromatase and/or sulphatase |
| 04/22/2008 | US7361633 Treating sex-hormone dependent tumors and cancer such as benign prostate hyperplasia and uterine fibroids with the decapeptide: Ac-D-Nal(2)-D-4-ClPhe-D-Pal-Ser-1 MePal-D-IsopropylLys-Leu-lsopropylLys-Pro-D-AlaNH2 |
| 04/22/2008 | US7361511 Comparing gene expression levels in normal and tumor cells, diagnosis, treating with an antisense oligonucleotide, and monitoring results |
| 04/22/2008 | US7361502 Nucleic acid molecule encoding a neuronal serine-threonine protein kinase |
| 04/22/2008 | US7361459 Antiviral inhibition of capsid proteins |
| 04/22/2008 | US7361358 Treating a non-spasm caused pain with botulinum toxin |
| 04/22/2008 | US7361345 monoclonal antibody prevents the growth or differentiation of the B cell; secreted by the hybridoma; therapy of autoimmune diseases, sytematic lupus erythematosus, primary biliary cirrhosis, and idiopathic thrombocytopenic purpura; biodrug |
| 04/22/2008 | US7361331 Plant bioreactors |
| 04/22/2008 | US7361329 Administering vaccine |
| 04/22/2008 | CA2390685C Methods and compositions for inhibiting neoplastic cell growth |
| 04/22/2008 | CA2356109C Insulin-like growth factor (igf) i mutant variants |
| 04/22/2008 | CA2321687C Combination of a selective nmda nr2b antagonist and a cox-2 inhibitor |
| 04/22/2008 | CA2319433C Targeted delivery of biologically active media |
| 04/22/2008 | CA2280183C Method of treating dry eye disease with purinergic receptor agonists |
| 04/22/2008 | CA2239582C A new therapeutic use for glycine |
| 04/22/2008 | CA2200195C Use of aromatase inhibitors for the production of a pharmaceutical agentfor treating a relative androgen deficiency in men |
| 04/22/2008 | CA2174737C Physiologically stable compositions of butyric acid, and butyric acid salts and derivatives as anti-neoplastic agents |
| 04/17/2008 | WO2008045641A2 Composition s comprising a benzodiazepine, an alcohol aversive agent and an abuse aversive agent |
| 04/17/2008 | WO2008045186A1 Method of treatment of otitis externa |
| 04/17/2008 | WO2008044928A1 Complement inhibition for improved nerve regeneration |
| 04/17/2008 | WO2008044777A1 2-pyridinecarboxamide derivative having gk-activating activity |
| 04/17/2008 | WO2008044660A1 Screening method for prokinetic agent |
| 04/17/2008 | WO2008044627A1 Prophylactic/therapeutic agent for liver disorder utilizing baculovirus |
| 04/17/2008 | WO2008044562A1 Pharmaceutical composition comprising phenylamidine derivative and method of using the pharmaceutical composition in combination with antifungal agent |
| 04/17/2008 | WO2008044339A1 Therapeutic/preventive agent for intraocular disease containing statin compound |
| 04/17/2008 | WO2008044054A2 Hydroxy-substituted benzoic acid amide compounds for use in therapy |
| 04/17/2008 | WO2008043701A1 Pharmaceutical solid dosage forms comprising compounds micro-embedded in ionic water-insoluble polymers |
| 04/17/2008 | WO2008027532A3 Pharmaceutical compositions including vitamin d and corticosteroid |
| 04/17/2008 | WO2008025926A3 Salivary substitute |
| 04/17/2008 | WO2008025848A3 Composition for eliciting a specific ctl response, comprising a lympho-ablative compound and a molecule that contains antigenic sequences and targets professional antigen presenting cells |
| 04/17/2008 | WO2008009589A3 Kit of parts comprising an acid labile and an acid resistant pharmaceutically active ingredient |
| 04/17/2008 | WO2008001184A3 Solid composition |
| 04/17/2008 | WO2007144084A3 Type-2 diabetes combination wafer |
| 04/17/2008 | WO2007144083A3 Ache-nmda combination wafer |
| 04/17/2008 | WO2007141667A3 Immunosuppressive extract of cordyceps sinensis and uses thereof |
| 04/17/2008 | WO2007115286A3 Combinations of therapeutic agents for treating cancer |
| 04/17/2008 | WO2007114978A3 Method for treating hiv infection through co-administration of tipranavir and pa-457 |
| 04/17/2008 | WO2007070629A3 Porphyromonas gingivalis 1435/1449 lps as an immune modulator |
| 04/17/2008 | WO2005020903A3 Methods of improving the safety of zonisamide therapy |
| 04/17/2008 | US20080091263 Apparatus and Methods for Preventing or Treating Failure of Hemodialysis Vascular Access and Other Vascular Grafts |
| 04/17/2008 | US20080090996 Thrombopoietin mimetics |
| 04/17/2008 | US20080090907 Crystal Comprising (2R)-2-Propyloctanoic Acid and Amine |
| 04/17/2008 | US20080090881 Treatment of diabetes with thiazolidinedione and metformin |
| 04/17/2008 | US20080090878 Pharmaceutical combinations and their use in treating gastrointestinal and abdominal viscera disorders |
| 04/17/2008 | US20080090860 Side effect reduction; 2-carboxy-4-(2-propoxy-3,5-di-tert-butylphenyl)-benzo[b]thiophene for example; syndrome X, non-insulin dependent diabetes mellitus, cancer, photoaging, acne, psoriasis, obesity, cardiovascular disease, atherosclerosis, uterine leiomyomata, inflamatory or neurodegenerative disease |
| 04/17/2008 | US20080090859 For example, N-methyl-N-[(1S)-1-phenyl-2-((3S)-3-hydroxypyrrolidin-1-yl) ethyl]-2,2-diphenylacetamide; for the diagnosis, prophylaxis and or the treatment of neuropathy, the clinical pictures and symptoms associated therewith, and related disorders |
| 04/17/2008 | US20080090843 Pharmaceutical formulation for treatment of HBV infection comprising a compound that inhibits the activity of a Src kinase in an amount effective to inhibit HBV replication and a pharmaceutically acceptable carrier |
| 04/17/2008 | US20080090842 Novel pyridyl cyanoguanidine compounds |
| 04/17/2008 | US20080090787 Thrombopoietin mimetics |
| 04/17/2008 | US20080090782 Inhibit DNA-dependent protein kinase; reduced side effects caused by radiation and chemotherapy drugs |
| 04/17/2008 | US20080090290 Nucleic Acids Encoding Anti-IL-12 Antibodies, and Methods of Production |
| 04/17/2008 | US20080090270 Neuronal binding protein for use tool in identifying modulators for prevention and treatment of nervous system disorders |
| 04/17/2008 | US20080090260 Peptide sequence for use as substrate in bioassays which monitor aspartyl protease activity |
| 04/17/2008 | US20080089963 Topical compositions containing Bacillus coagulans extracellular products and uses thereof |
| 04/17/2008 | US20080089956 Nitric oxide in treatment of inflammation |
| 04/17/2008 | US20080089950 Lymphoid tissue inducers and an immunomodulatory agent; proliferative disorders, infectious diseases, cardiovascular diseases, inflammatory disorders and autoimmune disorders |
| 04/17/2008 | US20080089893 therapeutic strategies which include the use of administration of immunologically active mouse/human chimeric anti-CD20 antibodies, radiolabeled anti-CD20 antibodies, and cooperative strategies comprising the use of chimeric anti-CD20 antibodies and radiolabeled anti-CD20 antibodies; Anticancer agent |
| 04/17/2008 | US20080089882 Novel Polypeptide Useful for Cancer Diagnosis and Treatment |
| 04/17/2008 | US20080089873 Method for Regenerating Hair Follicles by Suppressing a Gene with Hair Follicle Formation-Inhibiting Ability or by Activating a Gene with Hair Follicle Formation-Inducing Ability |
| 04/17/2008 | US20080089870 Cultured Melanocytes on Bioploymer Membranes for Treatment of Hyper and Hypopigmentation Disorders |
| 04/17/2008 | US20080089865 Nutrient broth comprising no cell attachment factors for use in propagation of neuronal cell lines |
| 04/17/2008 | US20080089864 Viral sequences for targeted replication in tumor cells |
| 04/17/2008 | CA2666466A1 Complement inhibition for improved nerve regeneration |
| 04/17/2008 | CA2666314A1 Intra-mammary teat sealant formulation and method of using same to reduce or eliminate visual defects in aged cheeses |
| 04/17/2008 | CA2665604A1 Pharmaceutical solid dosage forms comprising compounds micro-embedded in ionic water-insoluble polymers |
| 04/17/2008 | CA2664915A1 Pharmaceutical composition comprising phenylamidine derivative and method of using the pharmaceutical composition in combination with antifungal agent |
| 04/16/2008 | EP1911740A1 Potassium channel modulators |
| 04/16/2008 | EP1911494A2 Use of oligosaccharides to stimulate beta-endorphin production |
| 04/16/2008 | EP1911471A1 Agent for visualizing vitreous body |
| 04/16/2008 | EP1911463A1 Weight management system for obese animals |
| 04/16/2008 | EP1911462A2 Compositions comprising a sterol absorption inhibitor |